Measurement of the Cerebral Saturation for Assessment of Safety of Epidural Anaesthesia During Abdominal Surgery

May 17, 2017 updated by: Tomasz Skladzien, Jagiellonian University
Subsequent and non-randomised patients, adult patients qualified for major abdominal surgeries were enrolled

Study Overview

Study Type

Observational

Enrollment (Actual)

101

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Małpololskie
      • Cracow, Małpololskie, Poland, 31-501
        • University Hopital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

One hundred and one (101) subsequent and non-randomised patients, age between 35 and 84 years (mean 64±10) hospitalised at the 1st Department of General, Oncologic and Gastroenterologic Surgery of the UJ CM in Krakow, qualified for abdominal surgeries were enrolled.

Description

Inclusion Criteria:

  • scheduled for major abdominal surgery for at least 2 h
  • under general anesthesia
  • American Society of Anesthesiologists(ASA)physical status : II ~ III
  • Age > 18

Exclusion Criteria:

  • refuse of patients
  • patient with results of test: "The Mini Mental State Examination"" less then 24 before operation
  • neurosurgery history of patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
nirs
The cerebral oxymetry saturation was monitored continuously, using a non-invasive method. The cerebral saturation was monitored intraoperatively with near infrared spectroscopy (INVOS 4100; Somanetics Inc, Troy, MI). Data acquired from the device were automatically and continuously recorded in 10-second intervals throughout the anaesthesia. A lead for the cerebral saturation monitoring was placed on degreased skin on the patient's forehead, on the right side, some 1 cm over the eyebrow. The baseline value was determined before induction of anaesthesia. The following criteria were accepted as significant reduction of the cerebral oxygenation (saturation) value: reduction of the cerebral oxymetry by over 25% in relation to the baseline; the absolute value of cerebral oxymetry below 50%.
cognitive function
Upon the day preceding the actual surgery, and again at 5 days after the surgery, the Mini Mental State Examination test was completed, with a view to assessing the chang-es in the patients' cognitive function. The difference between score in Mini Mental State Examination higher than 2 points defined a diagnosis of cognitive dysfunction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cerebral saturation
Time Frame: every 5 minutes throughout the surgery
decreases in cerebral oxygen saturation (rSO2) during the surgery
every 5 minutes throughout the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the Mini Mental State Examination test
Time Frame: Baseline, 4 day after surgery
to assessing the changes in the patients' cognitive function
Baseline, 4 day after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Tomasz Składzień, Ph.D, University Hospital in Cracow

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (ACTUAL)

March 1, 2013

Study Completion (ACTUAL)

April 1, 2013

Study Registration Dates

First Submitted

May 16, 2016

First Submitted That Met QC Criteria

May 17, 2017

First Posted (ACTUAL)

May 19, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 19, 2017

Last Update Submitted That Met QC Criteria

May 17, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

  1. The day before the surgery will be performed basic blood tests (morphology, gas analysis) and test "Short Scale Mental State Examination."
  2. During the operation, in addition to standard monitoring the electrical activity of the heart, blood pressure and peripheral oxygen saturation levels, will be assessed non-invasively cerebral oximetry.
  3. When during general anesthesia bradycardia occurs, then half of the patients in this group will be set up into the esophagus electrode, which will provide the ability to route atrial pacing hemodynamically optimal heart rate (80 / min). However, in the second half of the patients at the time of the occurrence of bradycardia is given intravenously at a dose of atropine 0.5 mg.
  4. In about two hours after the surgery will be taken blood tests (morphology + gas analysis) to determine the potential impact of intraoperative bleeding changes oximetry.
  5. On postoperative day 5 will be repeated test "Short Scale Mental State Examination"

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Complications From General Anesthesia

3
Subscribe